StonvexLoading…
StonvexStonvexStonvexCore line items from PRMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.66B | $5.15B | $4.70B | $4.44B |
Operating Income | $430.40M | $360.30M | $406.00M | $23.30M |
Net Income | $60.10M | $-16.40M | $92.80M | $-126.70M |
EPS (Diluted) | $0.16 | $-0.07 | $0.29 | $-0.74 |
Total Assets | $10.60B | $11.19B | $5.15B | Not available |
Total Liabilities | $7.61B | $7.75B | $5.15B | Not available |
Cash & Equivalents | $376.70M | $613.70M | $44.70M | $105.80M |
Free Cash Flow OCF − CapEx | $302.90M | $313.60M | $117.30M | $-150.20M |
Shares Outstanding | 363.94M | 379.79M | 1.03M | 218.29M |